CT scans may help predict survival in rare lung infection
NCT ID NCT07339800
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study examines whether chest CT scans can help predict how patients with a rare but severe lung fungal infection called pulmonary mucormycosis will fare. Researchers will review scans from 80 patients treated at a French hospital to identify imaging patterns linked to better or worse outcomes. The goal is to improve follow-up and treatment decisions for this life-threatening infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use CT scans to better predict how patients with this rare lung infection will fare, guiding more personalized treatment.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear patterns, and results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY MUCORMYCOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France